RNA binding protein IGF2BP2 expression is induced by stress in the heart and mediates dilated cardiomyopathy

Miriam Krumbein1, Froma Oberman1, Yuval Cinnamon2

  • 1Department of Developmental Biology and Cancer Research, Institute for Medical Research-Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Communications Biology
|December 5, 2023
PubMed

Insights

Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) causes dilated cardiomyopathy when overexpressed in mice. However, reducing IGF2BP2 levels rescues heart function, suggesting it

Area of Science:

  • Molecular and Cellular Biology
  • Cardiovascular Research
  • RNA Biology

Background:

  • The Insulin-like growth factor 2 mRNA-binding protein (IGF2BP) family comprises three paralogs involved in RNA regulation.
  • While IGF2BP1 and IGF2BP3 are oncofetal proteins, IGF2BP2 persists in adult tissues, including the heart.
  • IGF2BP2 levels increase in cardiomyocytes during cardiac stress and remodeling.

Purpose of the Study:

  • To investigate the adaptive role of IGF2BP2 during cardiac stress and recovery.
  • To determine the functional consequences of IGF2BP2 overexpression in the heart.

Main Methods:

  • Utilized a conditional, inducible mouse model with enhanced IGF2BP2 expression.
  • Administered transgene downregulation to assess recovery.
  • Analyzed cardiac structure, sarcomeres, and mitochondrial morphology.

Main Results:

  • Overexpression of IGF2BP2 in mice led to dilated cardiomyopathy (DCM) and mortality.
  • Downregulation of IGF2BP2 expression rescued mice, enabling complete cardiac recovery.
  • Hearts overexpressing IGF2BP2 showed reduced sarcomeric and mitochondrial proteins, fragmented mitochondria, and altered sarcomere structure.

Conclusions:

  • IGF2BP2 plays a critical role in cardiac function and pathology.
  • Elevated IGF2BP2 levels are associated with cardiomyopathies in both mouse models and human patients.
  • IGF2BP2 represents a potential therapeutic target for treating cardiomyopathies.